Shengfeng Wang

796 total citations · 1 hit paper
34 papers, 514 citations indexed

About

Shengfeng Wang is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Shengfeng Wang has authored 34 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Shengfeng Wang's work include RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Inflammasome and immune disorders (4 papers). Shengfeng Wang is often cited by papers focused on RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Inflammasome and immune disorders (4 papers). Shengfeng Wang collaborates with scholars based in China, Belgium and United States. Shengfeng Wang's co-authors include Wenhu Zhou, Jinsong Ding, Kai Zhao, Zhenzhen Deng, Ruiheng Luo, Peng Liu, Ben Lü, Yuan Chen, Jing Li and Chunjiang Wang and has published in prestigious journals such as ACS Nano, Biomaterials and Journal of Controlled Release.

In The Last Decade

Shengfeng Wang

29 papers receiving 507 citations

Hit Papers

Intrinsic Radical Species Scavenging Activities of Tea Po... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengfeng Wang China 14 182 113 69 68 61 34 514
Chengxin Shi China 11 209 1.1× 93 0.8× 56 0.8× 86 1.3× 68 1.1× 13 539
Hyeongseop Keum South Korea 12 189 1.0× 125 1.1× 69 1.0× 97 1.4× 86 1.4× 27 573
Wonsik Jung South Korea 13 198 1.1× 138 1.2× 92 1.3× 114 1.7× 93 1.5× 22 553
Yunchun Zhao China 14 188 1.0× 101 0.9× 75 1.1× 97 1.4× 48 0.8× 33 592
Adrian T. Press Germany 14 201 1.1× 102 0.9× 84 1.2× 88 1.3× 38 0.6× 41 608
Chang‐Hee Whang South Korea 11 113 0.6× 93 0.8× 48 0.7× 63 0.9× 55 0.9× 20 350
Nele Geusens Belgium 8 257 1.4× 129 1.1× 140 2.0× 59 0.9× 49 0.8× 9 809
Chenxi Yang China 16 308 1.7× 116 1.0× 70 1.0× 132 1.9× 50 0.8× 45 763

Countries citing papers authored by Shengfeng Wang

Since Specialization
Citations

This map shows the geographic impact of Shengfeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengfeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengfeng Wang more than expected).

Fields of papers citing papers by Shengfeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengfeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengfeng Wang. The network helps show where Shengfeng Wang may publish in the future.

Co-authorship network of co-authors of Shengfeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shengfeng Wang. A scholar is included among the top collaborators of Shengfeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengfeng Wang. Shengfeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Ruiheng, Mingliang Ma, Dan Wang, et al.. (2025). GSK461364 Inhibits NLRP3 Inflammasome by Targeting NEK7 Phosphorylation. Advanced Science. 12(44). e04816–e04816.
3.
Xu, Richard Huan, et al.. (2024). Measurement properties of the EQ-5D-Y-3L, PedsQL 4.0, and PROMIS-25 Profile v2.0 in pediatric patients with spinal muscular atrophy. Health and Quality of Life Outcomes. 22(1). 50–50. 3 indexed citations
4.
Zeng, Ting, Long Liang, Wenjun Deng, et al.. (2024). BMAL1 plays a crucial role in immune homeostasis during sepsis-induced acute lung injury. Biochemical Pharmacology. 226. 116379–116379. 10 indexed citations
6.
Deng, Zhenzhen, et al.. (2023). IL-17 inhibitor-associated inflammatory bowel disease: A study based on literature and database analysis. Frontiers in Pharmacology. 14. 1124628–1124628. 46 indexed citations
7.
Liu, Leping, Hong Zheng, Shanshan Chen, Shengfeng Wang, & Minghua Yang. (2023). Heparin-induced thrombocytopenia associated with low-molecular-weight heparin: clinical feature analysis of cases and pharmacovigilance assessment of the FAERS database. Frontiers in Pharmacology. 14. 1247253–1247253. 4 indexed citations
8.
Deng, Zhenzhen, et al.. (2023). Rhabdomyolysis associated with newer-generation anti-seizure medications (ASMs): a real-world retrospective and pharmacovigilance study. Frontiers in Pharmacology. 14. 1197470–1197470. 8 indexed citations
9.
Wang, Jianglin, et al.. (2023). Antibiotic-associated vanishing bile duct syndrome: a real-world retrospective and pharmacovigilance database analysis. Infection. 52(3). 891–899. 3 indexed citations
10.
Chen, Yuan, Ruiheng Luo, Jing Li, et al.. (2022). Intrinsic Radical Species Scavenging Activities of Tea Polyphenols Nanoparticles Block Pyroptosis in Endotoxin-Induced Sepsis. ACS Nano. 16(2). 2429–2441. 138 indexed citations breakdown →
11.
Peng, Ying, et al.. (2022). Pure DNA scaffolded drug delivery systems for cancer therapy. Biomaterials. 285. 121532–121532. 26 indexed citations
12.
Wang, Shengmei, Xuanjun Liu, Shengfeng Wang, et al.. (2021). Imatinib co-loaded targeted realgar nanocrystal for synergistic therapy of chronic myeloid leukemia. Journal of Controlled Release. 338. 190–200. 18 indexed citations
14.
Wang, Shengfeng, Jinsong Ding, & Wenhu Zhou. (2019). An aptamer-tethered, DNAzyme-embedded molecular beacon for simultaneous detection and regulation of tumor-related genes in living cells. The Analyst. 144(17). 5098–5107. 13 indexed citations
15.
Li, Liang, Yingcai Meng, Ling Li, et al.. (2019). A tetrahedral DNA nanoflare for fluorometric determination of nucleic acids and imaging of microRNA using toehold strands. Microchimica Acta. 186(12). 824–824. 11 indexed citations
16.
Liu, Peng, et al.. (2019). A thermo-responsive and self-healing liposome-in-hydrogel system as an antitubercular drug carrier for localized bone tuberculosis therapy. International Journal of Pharmaceutics. 558. 101–109. 53 indexed citations
17.
Song, Liying, Weijin Fang, Yang He, et al.. (2019). Inhibitory effects of oxymatrine on hepatic stellate cells activation through TGF-β/miR-195/Smad signaling pathway. BMC Complementary and Alternative Medicine. 19(1). 138–138. 20 indexed citations
18.
Liu, Peng, Shengfeng Wang, Xuanjun Liu, Jinsong Ding, & Wenhu Zhou. (2018). Platinated graphene oxide: A nanoplatform for efficient gene-chemo combination cancer therapy. European Journal of Pharmaceutical Sciences. 121. 319–329. 20 indexed citations
19.
Wang, Shengfeng, Chuan Zhao, Peng Liu, et al.. (2017). Facile construction of dual-targeting delivery system by using lipid capped polymer nanoparticles for anti-glioma therapy. RSC Advances. 8(1). 444–453. 17 indexed citations
20.
Wang, Geng, Liming Li, Yonghua Hu, et al.. (2013). [Relationship between the clustering of risk factors and the prevalence of hypertension in the community residents living in Shanghai].. PubMed. 34(4). 307–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026